戻る Agendas
DEVELOPING BEST PRACTICE GUIDANCE ON PATIENT ENGAGEMENT IN MEDICINES R&D
Session Chair(s)
David Haerry
Patient Advocate
EATG, Switzerland
EUPATI IMI is developing best practice guidance on patient engagement with all relevant stakeholders (industry, ethics committees, health technology assessment bodies and regulatory agencies). This session aims to inform about the current status of the deliverable and to collect further feedback from the audience. Short introductory statements and Q&A on the present status of patient involvement in the context of: • Industry-led R&D • Ethics Committees • HTA
Speaker(s)
Patient Involvement in Industry-Led R&D
Matthias Gottwald
Bayer Pharma AG, Germany
Head R&D Policy and Networking
Patient Involvement in HTA
Karen Facey, PHD
University of Edinburgh, United Kingdom
Visiting Senior Research Fellow
Patient Involvement in Ethics Committees
Andrea Heckenberg, MSC
Medical University of Vienna, Austria
Senior Staff Member, Ethics Committee Office
Patient Involvement in Regulatory Agencies
Isabelle Moulon, MD
European Medicines Agency, Netherlands
Head of Patients and Healthcare Professionals Department